These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 34756276)

  • 1. Comparison of RNA-Based Next-Generation Sequencing Assays for the Detection of NTRK Gene Fusions.
    Park HJ; Baek I; Cheang G; Solomon JP; Song W
    J Mol Diagn; 2021 Nov; 23(11):1443-1451. PubMed ID: 34756276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods for Identifying Patients with Tropomyosin Receptor Kinase (TRK) Fusion Cancer.
    Wong D; Yip S; Sorensen PH
    Pathol Oncol Res; 2020 Jul; 26(3):1385-1399. PubMed ID: 31256325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting disease-defining gene fusions in unclassified round cell sarcomas using anchored multiplex PCR/targeted RNA next-generation sequencing-Molecular and clinicopathological characterization of 16 cases.
    Mantilla JG; Ricciotti RW; Chen E; Hoch BL; Liu YJ
    Genes Chromosomes Cancer; 2019 Oct; 58(10):713-722. PubMed ID: 31033080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NTRK fusion detection across multiple assays and 33,997 cases: diagnostic implications and pitfalls.
    Solomon JP; Linkov I; Rosado A; Mullaney K; Rosen EY; Frosina D; Jungbluth AA; Zehir A; Benayed R; Drilon A; Hyman DM; Ladanyi M; Sireci AN; Hechtman JF
    Mod Pathol; 2020 Jan; 33(1):38-46. PubMed ID: 31375766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
    Hasegawa N; Hayashi T; Niizuma H; Kikuta K; Imanishi J; Endo M; Ikeuchi H; Sasa K; Sano K; Hirabayashi K; Takagi T; Ishijima M; Kato S; Kohsaka S; Saito T; Suehara Y
    Clin Orthop Relat Res; 2024 Mar; 482(3):549-563. PubMed ID: 38014853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NAB2-STAT6 gene fusion in solitary fibrous tumor can be reliably detected by anchored multiplexed PCR for targeted next-generation sequencing.
    Guseva NV; Tanas MR; Stence AA; Sompallae R; Schade JC; Bossler AD; Bellizzi AM; Ma D
    Cancer Genet; 2016; 209(7-8):303-12. PubMed ID: 27292373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Feasibility and clinical utility of a pan-solid tumor targeted RNA fusion panel: A single center experience.
    Hindi I; Shen G; Tan Q; Cotzia P; Snuderl M; Feng X; Jour G
    Exp Mol Pathol; 2020 Jun; 114():104403. PubMed ID: 32061944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncogenic Gene Fusion Detection Using Anchored Multiplex Polymerase Chain Reaction Followed by Next Generation Sequencing.
    Seager M; Aisner DL; Davies KD
    J Vis Exp; 2019 Jul; (149):. PubMed ID: 31329176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESMO recommendations on the standard methods to detect NTRK fusions in daily practice and clinical research.
    Marchiò C; Scaltriti M; Ladanyi M; Iafrate AJ; Bibeau F; Dietel M; Hechtman JF; Troiani T; López-Rios F; Douillard JY; Andrè F; Reis-Filho JS
    Ann Oncol; 2019 Sep; 30(9):1417-1427. PubMed ID: 31268127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of NTRK fusion detection methods in microsatellite-instability-high metastatic colorectal cancer.
    Schraa SJ; Stelloo E; Laclé MM; Swennenhuis JF; Brosens LAA; Fijneman RJA; Feitsma H; Koopman M; de Leng WW; Vink GR; Bol GM
    Virchows Arch; 2023 Jun; 482(6):983-992. PubMed ID: 37067589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTRK Gene Fusion Detection in Atypical Spitz Tumors.
    Cappellesso R; Nozzoli F; Zito Marino F; Simi S; Castiglione F; De Giorgi V; Cota C; Senetta R; Scognamiglio G; Anniciello AM; Cesinaro AM; Mandalà M; Gianatti A; Valente MG; Valeri B; Sementa AR; Ricci C; Corti B; Roviello G; Dei Tos AP; Franco R; Massi D
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interlaboratory Comparison Study (Ring Test) of Next-Generation Sequencing-Based NTRK Fusion Detection in South Korea.
    Lee SE; Lee MS; Jeon YK; Shim HS; Kang J; Kim J; Choi YL
    Cancer Res Treat; 2023 Jan; 55(1):28-40. PubMed ID: 35167738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic testing approaches for the identification of patients with TRK fusion cancer prior to enrollment in clinical trials investigating larotrectinib.
    Rudzinski ER; Hechtman J; Roy-Chowdhuri S; Rudolph M; Lockwood CM; Silvertown J; Wierzbinska J; Shen K; Norenberg R; Nogai H; Hong DS; Drilon A; Laetsch TW
    Cancer Genet; 2022 Jan; 260-261():46-52. PubMed ID: 34929613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CANTRK: A Canadian Ring Study to Optimize Detection of NTRK Gene Fusions by Next-Generation RNA Sequencing.
    Stockley TL; Lo B; Box A; Corredor AG; DeCoteau J; Desmeules P; Feilotter H; Grafodatskaya D; Greer W; Hawkins C; Huang WY; Izevbaye I; Lépine G; Martins Filho SN; Papadakis AI; Park PC; Riviere JB; Sheffield BS; Spatz A; Spriggs E; Tran-Thanh D; Yip S; Zhang T; Torlakovic E; Tsao MS
    J Mol Diagn; 2023 Mar; 25(3):168-174. PubMed ID: 36586421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitive and specific detection of EML4-ALK rearrangements in non-small cell lung cancer (NSCLC) specimens by multiplex amplicon RNA massive parallel sequencing.
    Moskalev EA; Frohnauer J; Merkelbach-Bruse S; Schildhaus HU; Dimmler A; Schubert T; Boltze C; König H; Fuchs F; Sirbu H; Rieker RJ; Agaimy A; Hartmann A; Haller F
    Lung Cancer; 2014 Jun; 84(3):215-21. PubMed ID: 24674157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testing NTRK testing: Wet-lab and in silico comparison of RNA-based targeted sequencing assays.
    Pfarr N; Kirchner M; Lehmann U; Leichsenring J; Merkelbach-Bruse S; Glade J; Hummel M; Stögbauer F; Lehmann A; Trautmann M; Kumbrink J; Jung A; Dietmaier W; Endris V; Kazdal D; Evert M; Horst D; Kreipe H; Kirchner T; Wardelmann E; Lassen U; Büttner R; Weichert W; Dietel M; Schirmacher P; Stenzinger A
    Genes Chromosomes Cancer; 2020 Mar; 59(3):178-188. PubMed ID: 31652375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTRK gene fusion testing and management in lung cancer.
    Repetto M; Chiara Garassino M; Loong HH; Lopez-Rios F; Mok T; Peters S; Planchard D; Popat S; Rudzinski ER; Drilon A; Zhou C
    Cancer Treat Rev; 2024 Jun; 127():102733. PubMed ID: 38733648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NTRK fusions in thyroid cancer: Pathology and clinical aspects.
    Ma Y; Zhang Q; Zhang K; Liang Y; Ren F; Zhang J; Kan C; Han F; Sun X
    Crit Rev Oncol Hematol; 2023 Apr; 184():103957. PubMed ID: 36907364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating Targeted Next-Generation Sequencing Assays and Reference Materials for NTRK Fusion Detection.
    Bormann Chung C; Lee J; Barritault M; Bringuier PP; Xu Z; Huang WY; Beharry A; Castillo J; Christiansen J; Lin JC; Sheffield BS
    J Mol Diagn; 2022 Jan; 24(1):18-32. PubMed ID: 34656759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anchored multiplex PCR for targeted next-generation sequencing reveals recurrent and novel USP6 fusions and upregulation of USP6 expression in aneurysmal bone cyst.
    Guseva NV; Jaber O; Tanas MR; Stence AA; Sompallae R; Schade J; Fillman AN; Miller BJ; Bossler AD; Ma D
    Genes Chromosomes Cancer; 2017 Apr; 56(4):266-277. PubMed ID: 27910166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.